A tailored psychological intervention for anxiety and depression management in people with chronic obstructive pulmonary disease: TANDEM RCT and process evaluation.
ANXIETY
CHRONIC OBSTRUCTIVE
COGNITIVE BEHAVIOURAL THERAPY
DEPRESSION
ECONOMIC EVALUATION
PULMONARY DISEASE
QUALITATIVE RESEARCH
RANDOMISED CONTROLLED TRIAL
Journal
Health technology assessment (Winchester, England)
ISSN: 2046-4924
Titre abrégé: Health Technol Assess
Pays: England
ID NLM: 9706284
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
medline:
17
1
2024
pubmed:
17
1
2024
entrez:
17
1
2024
Statut:
ppublish
Résumé
People with chronic obstructive pulmonary disease have high levels of anxiety and depression, which is associated with increased morbidity and poor uptake of effective treatments, such as pulmonary rehabilitation. Cognitive-behavioural therapy improves mental health of people with long-term conditions and could potentially increase uptake of pulmonary rehabilitation, enabling synergies that could enhance the mental health of people with chronic obstructive pulmonary disease. Our aim was to develop and evaluate the clinical effectiveness and cost effectiveness of a tailored cognitive-behavioural approach intervention, which links into, and optimises the benefits of, routine pulmonary rehabilitation. We carried out a pragmatic multicentre randomised controlled trial using a 1.25 : 1 ratio (intervention : control) with a parallel process evaluation, including assessment of fidelity. Twelve NHS trusts and five Clinical Commissioning Groups in England were recruited into the study. The intervention was delivered in participant's own home or at a local NHS facility, and by telephone. Between July 2017 and March 2020 we recruited adults with moderate/very severe chronic obstructive pulmonary disease and mild/moderate anxiety and/or depression, meeting eligibility criteria for assessment for pulmonary rehabilitation. Carers of participants were invited to participate. The cognitive-behavioural approach intervention (i.e. six to eight 40- to 60-minute sessions plus telephone support throughout pulmonary rehabilitation) was delivered by 31 trained respiratory healthcare professionals to participants prior to commencing pulmonary rehabilitation. Usual care included routine pulmonary rehabilitation referral. Co-primary outcomes were Hospital Anxiety and Depression Scale - anxiety and Hospital Anxiety and Depression Scale - depression at 6 months post randomisation. Secondary outcomes at 6 and 12 months included health-related quality of life, smoking status, uptake of pulmonary rehabilitation and healthcare use. We analysed results from 423 randomised participants (intervention, The tailored cognitive-behavioural approach intervention delivered with fidelity by trained respiratory healthcare professionals to people with chronic obstructive pulmonary disease was neither clinically effective nor cost-effective. Alternative approaches that are integrated with routine long-term condition care are needed to address the unmet, complex clinical and psychosocial needs of this group of patients. This trial is registered as ISRCTN59537391. This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 13/146/02) and is published in full in People with long-standing lung problems, such as chronic obstructive pulmonary disease, often also have anxiety and depression, which further reduces their quality of life. Two existing treatments could help. Pulmonary rehabilitation (a programme of exercise and education) improves both the physical and mental health of people with chronic obstructive pulmonary disease. Cognitive–behavioural therapy (a talking therapy) may reduce anxiety and depression. The TANDEM [Tailored intervention for Anxiety and Depression Management in chronic obstructive pulmonary disease (COPD)] intervention linked these two treatments by providing talking therapy based on cognitive–behavioural therapy during the waiting time following referral for pulmonary rehabilitation. The TANDEM treatment was delivered by respiratory healthcare professionals (e.g. nurses or physiotherapists) trained to deliver the talking therapy in six to eight weekly sessions. The sessions were conducted in the participant’s home (or another convenient location), with brief telephone support during the pulmonary rehabilitation. Of 423 participants recruited to the study, 242 participants received TANDEM talking therapy and 181 participants received usual care (including a referral to pulmonary rehabilitation). We measured mental health, quality of life, social life, attendance at pulmonary rehabilitation and healthcare use in both groups at 6 and 12 months. Forty-three carers joined the study and we assessed their mental well-being. We interviewed patients, carers and health professionals to find out their views and experience of the TANDEM treatment. We also examined whether or not the TANDEM treatment was good value for money. The TANDEM treatment did not improve the mental or the physical health of people with chronic obstructive pulmonary disease. In addition, the TANDEM treatment cost the NHS an extra £770 per patient, which was not good value for money. The TANDEM treatment was well received, and many participants told us how it had helped them. Heath-care professionals noted how participants did not just have chronic obstructive pulmonary disease, but were coping with many physical, mental and social problems. The TANDEM intervention was not effective and, therefore, other strategies will be needed to help people with chronic obstructive pulmonary disease and mental health problems live with their condition.
Sections du résumé
Background
UNASSIGNED
People with chronic obstructive pulmonary disease have high levels of anxiety and depression, which is associated with increased morbidity and poor uptake of effective treatments, such as pulmonary rehabilitation. Cognitive-behavioural therapy improves mental health of people with long-term conditions and could potentially increase uptake of pulmonary rehabilitation, enabling synergies that could enhance the mental health of people with chronic obstructive pulmonary disease.
Aim
UNASSIGNED
Our aim was to develop and evaluate the clinical effectiveness and cost effectiveness of a tailored cognitive-behavioural approach intervention, which links into, and optimises the benefits of, routine pulmonary rehabilitation.
Design
UNASSIGNED
We carried out a pragmatic multicentre randomised controlled trial using a 1.25 : 1 ratio (intervention : control) with a parallel process evaluation, including assessment of fidelity.
Setting
UNASSIGNED
Twelve NHS trusts and five Clinical Commissioning Groups in England were recruited into the study. The intervention was delivered in participant's own home or at a local NHS facility, and by telephone.
Participants
UNASSIGNED
Between July 2017 and March 2020 we recruited adults with moderate/very severe chronic obstructive pulmonary disease and mild/moderate anxiety and/or depression, meeting eligibility criteria for assessment for pulmonary rehabilitation. Carers of participants were invited to participate.
Intervention
UNASSIGNED
The cognitive-behavioural approach intervention (i.e. six to eight 40- to 60-minute sessions plus telephone support throughout pulmonary rehabilitation) was delivered by 31 trained respiratory healthcare professionals to participants prior to commencing pulmonary rehabilitation. Usual care included routine pulmonary rehabilitation referral.
Main outcome measures
UNASSIGNED
Co-primary outcomes were Hospital Anxiety and Depression Scale - anxiety and Hospital Anxiety and Depression Scale - depression at 6 months post randomisation. Secondary outcomes at 6 and 12 months included health-related quality of life, smoking status, uptake of pulmonary rehabilitation and healthcare use.
Results
UNASSIGNED
We analysed results from 423 randomised participants (intervention,
Conclusions
UNASSIGNED
The tailored cognitive-behavioural approach intervention delivered with fidelity by trained respiratory healthcare professionals to people with chronic obstructive pulmonary disease was neither clinically effective nor cost-effective. Alternative approaches that are integrated with routine long-term condition care are needed to address the unmet, complex clinical and psychosocial needs of this group of patients.
Trial registration
UNASSIGNED
This trial is registered as ISRCTN59537391.
Funding
UNASSIGNED
This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 13/146/02) and is published in full in
People with long-standing lung problems, such as chronic obstructive pulmonary disease, often also have anxiety and depression, which further reduces their quality of life. Two existing treatments could help. Pulmonary rehabilitation (a programme of exercise and education) improves both the physical and mental health of people with chronic obstructive pulmonary disease. Cognitive–behavioural therapy (a talking therapy) may reduce anxiety and depression. The TANDEM [Tailored intervention for Anxiety and Depression Management in chronic obstructive pulmonary disease (COPD)] intervention linked these two treatments by providing talking therapy based on cognitive–behavioural therapy during the waiting time following referral for pulmonary rehabilitation. The TANDEM treatment was delivered by respiratory healthcare professionals (e.g. nurses or physiotherapists) trained to deliver the talking therapy in six to eight weekly sessions. The sessions were conducted in the participant’s home (or another convenient location), with brief telephone support during the pulmonary rehabilitation. Of 423 participants recruited to the study, 242 participants received TANDEM talking therapy and 181 participants received usual care (including a referral to pulmonary rehabilitation). We measured mental health, quality of life, social life, attendance at pulmonary rehabilitation and healthcare use in both groups at 6 and 12 months. Forty-three carers joined the study and we assessed their mental well-being. We interviewed patients, carers and health professionals to find out their views and experience of the TANDEM treatment. We also examined whether or not the TANDEM treatment was good value for money. The TANDEM treatment did not improve the mental or the physical health of people with chronic obstructive pulmonary disease. In addition, the TANDEM treatment cost the NHS an extra £770 per patient, which was not good value for money. The TANDEM treatment was well received, and many participants told us how it had helped them. Heath-care professionals noted how participants did not just have chronic obstructive pulmonary disease, but were coping with many physical, mental and social problems. The TANDEM intervention was not effective and, therefore, other strategies will be needed to help people with chronic obstructive pulmonary disease and mental health problems live with their condition.
Autres résumés
Type: plain-language-summary
(eng)
People with long-standing lung problems, such as chronic obstructive pulmonary disease, often also have anxiety and depression, which further reduces their quality of life. Two existing treatments could help. Pulmonary rehabilitation (a programme of exercise and education) improves both the physical and mental health of people with chronic obstructive pulmonary disease. Cognitive–behavioural therapy (a talking therapy) may reduce anxiety and depression. The TANDEM [Tailored intervention for Anxiety and Depression Management in chronic obstructive pulmonary disease (COPD)] intervention linked these two treatments by providing talking therapy based on cognitive–behavioural therapy during the waiting time following referral for pulmonary rehabilitation. The TANDEM treatment was delivered by respiratory healthcare professionals (e.g. nurses or physiotherapists) trained to deliver the talking therapy in six to eight weekly sessions. The sessions were conducted in the participant’s home (or another convenient location), with brief telephone support during the pulmonary rehabilitation. Of 423 participants recruited to the study, 242 participants received TANDEM talking therapy and 181 participants received usual care (including a referral to pulmonary rehabilitation). We measured mental health, quality of life, social life, attendance at pulmonary rehabilitation and healthcare use in both groups at 6 and 12 months. Forty-three carers joined the study and we assessed their mental well-being. We interviewed patients, carers and health professionals to find out their views and experience of the TANDEM treatment. We also examined whether or not the TANDEM treatment was good value for money. The TANDEM treatment did not improve the mental or the physical health of people with chronic obstructive pulmonary disease. In addition, the TANDEM treatment cost the NHS an extra £770 per patient, which was not good value for money. The TANDEM treatment was well received, and many participants told us how it had helped them. Heath-care professionals noted how participants did not just have chronic obstructive pulmonary disease, but were coping with many physical, mental and social problems. The TANDEM intervention was not effective and, therefore, other strategies will be needed to help people with chronic obstructive pulmonary disease and mental health problems live with their condition.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-129Références
Lange P, Celli B, Agustí A, Boje Jensen G, Divo M, Faner R, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 2015;373:111–22. https://doi.org/10.1056/NEJMoa1411532
National Institute of Health and Care Excellence. Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management. NICE guideline [NG115]. URL: www.nice.org.uk/guidance/ng115 (accessed 24 October 2021).
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Prevention, Diagnosis and Management of COPD 2020 Report. URL: https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.1wms.pdf (accessed 24 October 2021).
World Health Organization. Chronic Obstructive Pulmonary Disease (COPD). URL: www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) (accessed 22 October 2021).
Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Mölken MR. Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis 2010;5:435–44. https://doi.org/10.2147/COPD.S13826
Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012;67:957–63. https://doi.org/10.1136/thoraxjnl-2011-201518
Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775–89.
Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020;8:585–96.
Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Health Epidemiol Genom 2018;3:e4.
British Lung Foundation. Chronic Obstructive Pulmonary Disease (COPD) Statistics. URL: https://statistics.blf.org.uk/copd?_ga=2.219875801.1367299004.1527163268-1758129798.1527163268 (accessed 24 October 2021).
Public Health England. The 2nd Atlas of Variation in Risk Factors and Healthcare for Respiratory Disease in England. URL: https://fingertips.phe.org.uk/profile/atlas-of-variation (accessed 24 October 2021).
The Lancet. UK COPD treatment: failing to progress. Lancet 2018;391:1550.
Early F, Lettis M, Winders SJ, Fuld J. What matters to people with COPD: outputs from Working Together for Change. NPJ Prim Care Respir Med 2019;29:11. https://doi.org/10.1038/s41533-019-0124-z
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012;380:37–43. https://doi.org/10.1016/S0140-6736(12)60240-2
Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med 2015;3:631–9. https://doi.org/10.1016/S2213-2600(15)00241-6
de Torres JP, Marín JM, Casanova C, Cote C, Carrizo S, Cordoba-Lanus E, et al. Lung cancer in patients with chronic obstructive pulmonary disease – incidence and predicting factors. Am J Respir Crit Care Med 2011;184:913–9. https://doi.org/10.1164/rccm.201103-0430OC
Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J 2006;28:1245–57.
Sampaio MS, Vieira WA, Bernardino ÍM, Herval ÁM, Flores-Mir C, Paranhos LR. Chronic obstructive pulmonary disease as a risk factor for suicide: a systematic review and meta-analysis. Respir Med 2019;151:11–8.
Tselebis A, Pachi A, Ilias I, Kosmas E, Bratis D, Moussas G, Tzanakis N. Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Neuropsychiatr Dis Treat 2016;12:297–328. https://doi.org/10.2147/NDT.S79354
Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL. Anxiety and depression – important psychological comorbidities of COPD. J Thorac Dis 2014;6:1615–31. https://doi.org/10.3978/j.issn.2072-1439.2014.09.28
Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev 2014;23:345–9. https://doi.org/10.1183/09059180.00007813
Koskela J, Kilpeläinen M, Kupiainen H, Mazur W, Sintonen H, Boezen M, et al. Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD. BMC Pulm Med 2014;14:102. https://doi.org/10.1186/1471-2466-14-102
Pooler A, Beech R. Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J Chron Obstruct Pulmon Dis 2014;9:315–30. https://doi.org/10.2147/COPD.S53255
Gardener AC, Ewing G, Kuhn I, Farquhar M. Support needs of patients with COPD: a systematic literature search and narrative review. Int J Chron Obstruct Pulmon Dis 2018;13:1021–35. https://doi.org/10.2147/COPD.S155622
National Institute for Health and Care Excellence. Depression in Adults: Recognition and Management. Clinical guideline [CG90]. URL: www.nice.org.uk/guidance/cg90 (accessed 25 October 2021).
National Institute for Health and Clinical Excellence. Generalised Anxiety Disorder and Panic Disorder in Adults: Management. Clinical guideline [CG113]. URL: www.nice.org.uk/guidance/cg113 (accessed 30 October 2021).
Beck AT. The Diagnosis and Management of Depression. Philadelphia, PA: University of Pennsylvania Press; 1967.
Greenberger D, Padesky C. Mind over Mood. A Cognitive Therapy Treatment Manual for Clients. New York, NY: Guilford Press; 1995.
Shafran R, Myles-Hooton P, Bennett S, Öst LG. The concept and definition of ‘low intensity’ cognitive behaviour therapy. Behaviour Res Therapy 2021;138:103803.
Olthuis JV, Watt MC, Bailey K, Hayden JA, Stewart SH. Therapist-supported internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev 2016;3:CD011565. https://doi.org/10.1002/14651858.CD011565.pub2
Hunot V, Churchill R, Silva de Lima M, Teixeira V. Psychological therapies for generalised anxiety disorder. Cochrane Database Syst Rev 2007;1:CD001848. https://doi.org/10.1002/14651858.CD001848.pub4
Norton PJ, Price EC. A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. J Nerv Ment Dis 2007;195:521–31. https://doi.org/10.1097/01.nmd.0000253843.70149.9a
Stewart RE, Chambless DL. Cognitive–behavioral therapy for adult anxiety disorders in clinical practice: a meta-analysis of effectiveness studies. J Consult Clin Psychol 2009;77:595–606. https://doi.org/10.1037/a0016032
Hofmann SG, Smits JA. Cognitive–behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry 2008;69:621–32.
Ijaz S, Davies P, Williams CJ, Kessler D, Lewis G, Wiles N. Psychological therapies for treatment-resistant depression in adults. Cochrane Database Syst Rev 2018;5:CD010558. https://doi.org/10.1002/14651858.CD010558.pub2
Wilson KC, Mottram PG, Vassilas CA. Psychotherapeutic treatments for older depressed people. Cochrane Database Syst Rev 2008;1:CD004853. https://doi.org/10.1002/14651858.CD004853.pub2
National Collaborating Centre for Mental Health. The Improving Access to Psychological Therapies (IAPT) Pathway for People with Long-term Physical Health Conditions and Medically Unexplained Symptoms. Full Implementation Guidance. London: National Collaborating Centre for Mental Health; 2018.
National Institute for Health and Care Excellence. Depression in Adults with a Chronic Physical Health Problem: Recognition and Management. Clinical guideline [CG91]. URL: www.nice.org.uk/guidance/cg91 (accessed 19 October 2021).
Clark DM. Implementing NICE guidelines for the psychological treatment of depression and anxiety disorders: the IAPT experience. Int Rev Psychiatry 2011;23:318–27. https://doi.org/10.3109/09540261.2011.606803
Beltman MW, Voshaar RC, Speckens AE. Cognitive–behavioural therapy for depression in people with a somatic disease: meta-analysis of randomised controlled trials. Br J Psychiatry 2010;197:11–9. https://doi.org/10.1192/bjp.bp.109.064675
van Straten A, Geraedts A, Verdonck-de Leeuw I, Andersson G, Cuijpers P. Psychological treatment of depressive symptoms in patients with medical disorders: a meta-analysis. J Psychosom Res 2010;69:23–32. https://doi.org/10.1016/j.jpsychores.2010.01.019
Reavell J, Hopkinson M, Clarkesmith D, Lane DA. Effectiveness of cognitive behavioral therapy for depression and anxiety in patients with cardiovascular disease: a systematic review and meta-analysis. Psychosom Med 2018;80:742–53. https://doi.org/10.1097/PSY.0000000000000626
Sanjida S, McPhail SM, Shaw J, Couper J, Kissane D, Price MA, Janda M. Are psychological interventions effective on anxiety in cancer patients? A systematic review and meta-analyses. Psychooncology 2018;27:2063–76. https://doi.org/10.1002/pon.4794
Lamb SE, Lall R, Hansen Z, Castelnuovo E, Withers EJ, Nichols V, et al. A multicentred randomised controlled trial of a primary care-based cognitive behavioural programme for low back pain. The Back Skills Training (BeST) trial. Health Technol Assess 2010;14(41). https://doi.org/10.3310/hta14410
Pollok J, van Agteren JE, Esterman AJ, Carson-Chahhoud KV. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2019;3:CD012347. https://doi.org/10.1002/14651858.CD012347.pub2
Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, et al. BTS guideline on pulmonary rehabilitation in adults. Thorax 2013;68:ii1–ii30.
Rochester CL, Vogiatzis I, Holland AE, Lareau SC, Marciniuk DD, Puhan MA, et al. ATS/ERS statement: enhancing implementation, use and delivery of PR. Am J Respir Crit Care Med 2105;192:1373–86.
Primary Care Respiratory Society. Chronic Obstructive Pulmonary Disease (COPD) Pathway. URL: www.england.nhs.uk/rightcare/products/pathways/chronic-obstructive-pulmonary-disease-copd-pathway (accessed 24 October 2021).
Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959;2:257–66.
McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015;2:CD003793. https://doi.org/10.1002/14651858.CD003793.pub3
Guo SE, Bruce A. Improving understanding of and adherence to pulmonary rehabilitation in patients with COPD: a qualitative inquiry of patient and health professional perspectives. PLOS ONE 2014;9:e110835. https://doi.org/10.1371/journal.pone.0110835
Williams MT, Johnston KN, Paquet C. Cognitive behavioral therapy for people with chronic obstructive pulmonary disease: rapid review. Int J Chron Obstruct Pulmon Dis 2020;15:903–19. https://doi.org/10.2147/COPD.S178049
Early F, Wilson PM, Deaton C, Wellwood I, Haque HW, Fox SE, et al. Pulmonary rehabilitation referral and uptake from primary care for people living with COPD: a mixed-methods study. ERJ Open Res 2020;6:00219–2019.
Steiner M, Lowe D, Searle L, Skipper E, Welham S, Roberts CM. Pulmonary Rehabilitation: Time to Breath Better. URL: www.rcplondon.ac.uk/projects/outputs/pulmonary-rehabilitation-time-breathe-better (accessed October 2021).
Steiner M, McMillan V, Lowe D, Holzhauer-Barrie J, Mortier K, Riordan J, et al. Pulmonary Rehabilitation: An Exercise in Improvement – Combined Clinical and Organisational Audit 2017. URL: www.rcplondon.ac.uk/projects/outputs/pulmonary-rehabilitation-exercise-improvement-combined-clinical-and-organisational (accessed October 2021).
Stone PW, Hickman K, Steiner MC, Roberts CM, Quint JK, Singh SJ. Predictors of pulmonary rehabilitation completion in the UK. ERJ Open Res 2021;7:00509–2020.
Liu Y, Dickerson T, Early F, Fuld J, Jiang C, Clarkson PJ. Understanding the influences of COPD patient’s capability on the uptake of pulmonary rehabilitation in the UK through an inclusive design approach. Int J Chron Obstruct Pulmon Dis 2021;16:1717–40. https://doi.org/10.2147/COPD.S305145
Early F, Wellwood I, Kuhn I, Deaton C, Fuld J. Interventions to increase referral and uptake to pulmonary rehabilitation in people with COPD: a systematic review. Int J Chron Obstruct Pulmon Dis 2018;13:3571–86. https://doi.org/10.2147/COPD.S172239
Zwar NA, Hermiz O, Comino E, Middleton S, Vagholkar S, Xuan W, et al. Care of patients with a diagnosis of chronic obstructive pulmonary disease: a cluster randomised controlled trial. Med J Aust 2012;197:394–8.
Harris M, Smith BJ, Veale AJ, Esterman A, Frith PA, Selim P. Providing reviews of evidence to COPD patients: controlled prospective 12-month trial. Chron Respir Dis 2009;6:165–73. https://doi.org/10.1177/1479972309106577
Cox NS, Oliveira CC, Lahham A, Holland AE. Pulmonary rehabilitation referral and participation are commonly influenced by environment, knowledge, and beliefs about consequences: a systematic review using the theoretical domains framework. J Physiother 2017;63:84–93.
National Institute for Health and Care Research. Research Award: A Tailored, Cognitive Behavioural Approach Intervention for Mild to Moderate Anxiety and/or Depression in People with Chronic Obstructive Pulmonary Disease (COPD): A Randomised Controlled Trial (TANDEM Tailored intervention for ANxiety and DEpression Management in COPD). URL: https://fundingawards.nihr.ac.uk/award/13/146/02 (accessed 19 October 2021).
Coventry PA, Bower P, Keyworth C, Kenning C, Knopp J, Garrett C, et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLOS ONE 2013;8:e60532. https://doi.org/10.1371/journal.pone.0060532
Barradell A, Sohanpal R. Patient and public involvement and its vital role in the TANDEM COPD study: a randomised controlled trial. EMJ Respir 2017;5:56–8.
Kelly M, Steed L, Sohanpal R, Pinnock H, Barradell A, Dibao-Dina C, et al. The TANDEM trial: protocol for the process evaluation of a randomised trial of a complex intervention for anxiety and/or depression in people living with chronic obstructive pulmonary disease (COPD). Trials 2021;22:495. https://doi.org/10.1186/s13063-021-05460-w
Steed L, Heslop-Marshall K, Sohanpal R, Saqi-Waseem S, Kelly M, Pinnock H, Taylor S. Developing a complex intervention whilst considering implementation: the TANDEM (Tailored intervention for ANxiety and DEpression Management) intervention for patients with chronic obstructive pulmonary disease (COPD). Trials 2021;22:252. https://doi.org/10.1186/s13063-021-05203-x
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655. https://doi.org/10.1136/bmj.a1655
Yardley L, Ainsworth B, Arden-Close E, Muller I. The person-based approach to enhancing the acceptability and feasibility of interventions. Pilot Feasibility Stud 2015;1:37. https://doi.org/10.1186/s40814-015-0033-z
Yardley L, Morrison L, Bradbury K, Muller I. The person-based approach to intervention development: application to digital health-related behavior change interventions. J Med Internet Res 2015;17:e30. https://doi.org/10.2196/jmir.4055
Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ 2021;374:n2061. https://doi.org/10.1136/bmj.n2061
Heslop-Marshall K, Baker C, Carrick-Sen D, Newton J, Echevarria C, Stenton C, et al. Randomised controlled trial of cognitive behavioural therapy in COPD. ERJ Open Res 2018;4:00094–2018.
Heslop K, Newton J, Baker C, Burns G, Carrick-Sen D, De Soyza A. Effectiveness of cognitive behavioural therapy (CBT) interventions for anxiety in patients with chronic obstructive pulmonary disease (COPD) undertaken by respiratory nurses: the COPD CBT CARE study: (ISRCTN55206395). BMC Pulm Med 2013;13:62. https://doi.org/10.1186/1471-2466-13-62
Apps LD, Mitchell KE, Harrison SL, Sewell L, Williams JE, Young HM, et al. The development and pilot testing of the self-management programme of activity, coping and education for chronic obstructive pulmonary disease (SPACE for COPD). Int J Chron Obstruct Pulmon Dis 2013;8:317–27. https://doi.org/10.2147/COPD.S40414
National Institute for Health and Care Excellence. Common Mental Health Problems: Identification and Pathways to Care. Clinical guideline [CG123]. URL: www.nice.org.uk/guidance/cg123 (accessed 19 October 2021).
Bandura A. Self-efficacy: The Exercise of Control. New York, NY: Freeman; 1997.
Smith SM, Sonego S, Ketcheson L, Larson JL. A review of the effectiveness of psychological interventions used for anxiety and depression in chronic obstructive pulmonary disease. BMJ Open Respir Res 2014;1:e000042. https://doi.org/10.1136/bmjresp-2014-000042
Ma RC, Yin YY, Wang YQ, Liu X, Xie J. Effectiveness of cognitive behavioural therapy for chronic obstructive pulmonary disease patients: a systematic review and meta-analysis. Complement Ther Clin Pract 2020;38:101071.
Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13–64. https://doi.org/10.1164/rccm.201309-1634ST
National Asthma and Chronic Obstructive Pulmonary Disease Audit Programme (NACAP). Pulmonary Rehabilitation Clinical and Organisational Audits 2019. URL: www.nacap.org.uk/nacap/welcome.nsf/reportsPR.html (accessed 19 October 2021).
Sohanpal R, Steed L, Mars T, Taylor SJ. Understanding patient participation behaviour in studies of COPD support programmes such as pulmonary rehabilitation and self-management: a qualitative synthesis with application of theory. NPJ Prim Care Respir Med 2015;25:15054. https://doi.org/10.1038/npjpcrm.2015.54
Leventhal L, Leventhal E. Representations, procedures and affect in illness self regulation. In Baum A, Revenson TA, Singer J, editors. Handbook of Health Psychology. New York, NY: Erlbaum; 1997.
Vaske I, Kenn K, Keil DC, Rief W, Stenzel NM. Illness perceptions and coping with disease in chronic obstructive pulmonary disease: effects on health-related quality of life. J Health Psychol 2017;22:1570–81. https://doi.org/10.1177/1359105316631197
Tiemensma J, Gaab E, Voorhaar M, Asijee G, Kaptein AA. Illness perceptions and coping determine quality of life in COPD patients. Int J Chron Obstruct Pulmon Dis 2016;11:2001–7. https://doi.org/10.2147/COPD.S109227
Howard C, Dupont S. ‘The COPD breathlessness manual’: a randomised controlled trial to test a cognitive–behavioural manual versus information booklets on health service use, mood and health status, in patients with chronic obstructive pulmonary disease. NPJ Prim Care Respir Med 2014;24:14076. https://doi.org/10.1038/npjpcrm.2014.76
Hagger MS, Orbell S. The common sense model of illness self-regulation: a conceptual review and proposed extended model [published online ahead of print February 01 2021]. Health Psychol Rev 2021. https://doi.org/10.1080/17437199.2021.1878050
O’Cathain A, Croot L, Duncan E, Rousseau N, Sworn K, Turner KM, et al. Guidance on how to develop complex interventions to improve health and healthcare. BMJ Open 2019;9:e029954. https://doi.org/10.1136/bmjopen-2019-029954
Fleming N. Helping students understand how they learn. Teach Prof 1992;7:a1655.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13.
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092–7.
University of Exeter. LI-IAPT Handbooks and Resources. URL: https://cedar.exeter.ac.uk/iapt/lihandbook (accessed 19 October 2021).
Rothman S, Pilling S. The Competencies Required to Deliver Effective Cognitive and Behavioural Therapy for People with Depression and with Anxiety Disorders. London: University College London; 2007.
Williams B, Song JJY. Are simulated patients effective in facilitating development of clinical competence for healthcare students? A scoping review. Adv Simul 2016;1:6. https://doi.org/10.1186/s41077-016-0006-1
Waller G, Turner H. Therapist drift redux: why well-meaning clinicians fail to deliver evidence-based therapy, and how to get back on track. Behav Res Ther 2016;77:129–37. https://doi.org/10.1016/j.brat.2015.12.005
Alfonsson S, Parling T, Spännargård Å, Andersson G, Lundgren T. The effects of clinical supervision on supervisees and patients in cognitive behavioral therapy: a systematic review. Cogn Behav Ther 2018;47:206–28. https://doi.org/10.1080/16506073.2017.1369559
Bellg AJ, Borelli B, Resnick B, Hecht J, Minicucci DS, Ory M, et al. Treatment Fidelity Workgroup of the NIH Behavior Change Consortium. Enhancing treatment fidelity in health behaviour change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol 2004;23:443–51.
Toomey E, Hardeman W, Hankonen N, Byrne M, McSharry J, Matvienko-Sikar K, Lorencatto F. Focusing on fidelity: narrative review and recommendations for improving intervention fidelity within trials of health behaviour change interventions. Health Psychol Behav Med 2020;8:132–51. https://doi.org/10.1080/21642850.2020.1738935
Steed L, Heslop-Marshall K, Sohanpal R, Saqi-Waseem S, Kelly M, Pinnock H, et al. A Five-Step Process for Designing Implementable Complex Interventions: A Worked Example using the Tailored Intervention for ANxiety and DEpression Management (TANDEM) for Patients with Chronic Obstructive Pulmonary Disease (COPD). URL: www.researchsquare.com/article/rs-29318/v1 (accessed 25 October 2022).
Sohanpal R, Pinnock H, Steed L, Heslop Marshall K, Chan C, Kelly M, et al. Tailored, psychological intervention for anxiety or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): protocol for a randomised controlled trial. Trials 2020;21:18. https://doi.org/10.1186/s13063-019-3800-y
Chan CL, Smuk M, Sohanpal R, Pinnock H, Taylor SJC, TANDEM Investigators. Tailored, psychological intervention for anxiety and/or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): statistical analysis plan for a randomised controlled trial. Trials 2020;21:858. https://doi.org/10.1186/s13063-020-04786-1
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
Association of Respiratory Technology and Physiology. Guidance on Quality Assured Diagnostic Spirometry. URL: www.artp.org.uk/Guidelines/05ea8b6f-f5d7-4fd2-828f-128e06d2111b (accessed 7 November 2021).
Berkshire Healthcare NHS Foundation Trust. Protocol and Procedure for Undertaking Spirometry in a Community Setting. URL: www.berkshirewestccg.nhs.uk/media/1597/spirometry.pdf (accessed 7 November 2021).
Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007;167:60–7.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69–77.
Cameron IM, Crawford JR, Lawton K, Reid IC. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. Br J Gen Pract 2008;58:32–6. https://doi.org/10.3399/bjgp08X263794
Howard C, Dupont S, Haselden B, Lynch J, Wills P. The effectiveness of a group cognitive-behavioural breathlessness intervention on health status, mood and hospital admissions in elderly patients with chronic obstructive pulmonary disease. Psychol Health Med 2010;15:371–85. https://doi.org/10.1080/13548506.2010.482142
Livermore N, Sharpe L, McKenzie D. Prevention of panic attacks and panic disorder in COPD. Eur Respir J 2010;35:557–63. https://doi.org/10.1183/09031936.00060309
Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362–8.
Dowson C, Laing R, Barraclough R, Town I, Mulder R, Norris K, Drennan C. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. N Z Med J 2001;114:447–9.
Arnau RC, Meagher MW, Norris MP, Bramson R. Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychol 2001;20:112–9. https://doi.org/10.1037//0278-6133.20.2.112
Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000;41:465–71.
PsychVisit. Beck Depression Inventory – 2nd Edition (BDI-II). URL: https://www.pearsonclinical.co.uk/store/ukassessments/en/Store/Professional-Assessments/Personality-%26-Biopsychosocial/Beck-Depression-Inventory-II/p/P100009013.html (accessed 24 September 2023).
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893–7. https://doi.org/10.1037//0022-006x.56.6.893
Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321–7. https://doi.org/10.1164/ajrccm/145.6.1321
Jones P. St George’s Respiratory Questionnaire for COPD Patients (SGRQ-C). URL: www.sgul.ac.uk/about/our-institutes/infection-and-immunity/research-themes/research-centres/health-status/sgrq (accessed 7 November 2021).
Osborne RH, Elsworth GR, Whitfield K. The Health Education Impact Questionnaire (heiQ): an outcomes and evaluation measure for patient education and self-management interventions for people with chronic conditions. Patient Educ Couns 2007;66:192–201.
Sullivan O, Gershuny J. Speed-up society? Evidence from the UK 2000 and 2015 time use diary surveys. Sociology 2018;52:20–38.
Priebe S, Savill M, Wykes T, Bentall RP, Reininghaus U, Lauber C, et al. Effectiveness of group body psychotherapy for negative symptoms of schizophrenia: multicentre randomised controlled trial. Br J Psychiatry 2016;209:54–61. https://doi.org/10.1192/bjp.bp.115.171397
Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res 2006;60:631–7.
Office of National Statistics. Opinions Survey Report No. 40 Smoking Related Behaviour and Attitudes, 2008/09. URL: https://webarchive.nationalarchives.gov.uk/ukgwa/20160109212138/www.ons.gov.uk/ons/rel/lifestyles/smoking-related-behaviour-and-attitudes/2008-09/index.html (accessed 30 October 2021).
Royal College of Physicians. National Asthma and COPD Audit Programme. URL: www.rcplondon.ac.uk/projects/national-asthma-and-copd-audit-programme-nacap (accessed 25 October 2021).
EQ-5D. About EQ-5D-5L. URL: https://euroqol.org/eq-5d-instruments/eq-5d-5l-about (accessed 15 October 2021).
Personal Social Services Research Unit. Client Service Receipt Inventory. URL: www.pssru.ac.uk/csri/client-service-receipt-inventory (accessed 19 October 2021).
Maheswaran H, Weich S, Powell J, Stewart-Brown S. Evaluating the responsiveness of the Warwick Edinburgh Mental Well-Being Scale (WEMWBS): group and individual level analysis. Health Qual Life Outcomes 2012;10:156. https://doi.org/10.1186/1477-7525-10-156
Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 1980;20:649–55. https://doi.org/10.1093/geront/20.6.649
Grant M, Cavanagh A, Yorke J. The impact of caring for those with chronic obstructive pulmonary disease (COPD) on carers’ psychological well-being: a narrative review. Int J Nurs Stud 2012;49:1459–71. https://doi.org/10.1016/j.ijnurstu.2012.02.010
Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005;26:414–9.
Puhan MA, Frey M, Büchi S, Schünemann HJ. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes 2008;6:46. https://doi.org/10.1186/1477-7525-6-46
Moerbeek M, Wong WK. Sample size formulae for trials comparing group and individual treatments in a multilevel model. Stat Med 2008;27:2850–64. https://doi.org/10.1002/sim.3115
White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ 2011;342:d40. https://doi.org/10.1136/bmj.d40
White IR, Carpenter J, Evans S, Schroter S. Eliciting and using expert opinions about dropout bias in randomized controlled trials. Clin Trials 2007;4:125–39.
Hewitt CE, Torgerson DJ, Miles JN. Is there another way to take account of noncompliance in randomized controlled trials? Can Med J 2006;175:347.
Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800–2.
Candlish J, Teare MD, Dimairo M, Flight L, Mandefield L, Walters SJ. Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study. BMC Med Res Methodol 2018;18:105. https://doi.org/10.1186/s12874-018-0559-x
Bell ML, Fairclough DL, Fiero MH, Butow PN, Handling missing items in the Hospital Anxiety and Depression Scale (HADS): a simulation study. BMC Research Notes 2016;9:479–88.
Warwick Medical School. Warwick–Edinburgh Mental Well-being Scales – WEMWBS User Guide Version 1. URL: https://warwick.ac.uk/fac/sci/med/research/platform/wemwbs/ (accessed 7 November 2021).
Lemay KR, Tulloch HE, Pipe AL, Reed JL. Establishing the minimal clinically important difference for the Hospital Anxiety and Depression Scale in patients with cardiovascular disease. J Cardiopulm Rehabil Prev 2019;39:E6–11. https://doi.org/10.1097/HCR.0000000000000379
Smid DE, Franssen FM, Houben-Wilke S, Vanfleteren LE, Janssen DJ, Wouters EF, Spruit MA. Responsiveness and MCID estimates for CAT, CCQ, and HADS in patients with COPD undergoing pulmonary rehabilitation: a prospective analysis. J Am Med Dir Assoc 2017;18:53–8.
Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, GW Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 4th edn. Oxford: Oxford University Press; 2015.
Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998;18:68–80. https://doi.org/10.1177/0272989X98018002S09
National Institute for Health and Care Excellence. NICE Health Technology Evaluations: The Manual. 2022. URL: www.nice.org.uk/process/pmg36/resources/nice-health-technology-evaluations-the-manual-pdf-72286779244741 (accessed 25 February 2022).
Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. 2nd edn. Oxford: Oxford University Press; 2015.
Beecham J, Knapp M. Costing psychiatric services. In Thornicroft G, Brewin C, Wing J, editors. Measuring Mental Health. London: Gaskell; 2000.
NHS Digital. Reference Costs 2019/20. URL: https://digital.nhs.uk/data-and-information/data-collections-and-data-sets/data-collections/reference-costs (accessed 6 November 2021).
Curtis L, Burns A. Unit Costs of Health and Social Care 2020. URL: www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2020 (accessed 6 November 2021).
Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 2013;22:1717–27. https://doi.org/10.1007/s11136-012-0322-4
National Institute for Health and Care Excellence. Position Statement on Use of the EQ-5D-5L Value Set for England (Updated October 2019). URL: www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l (accessed 6 November 2021).
van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708–15. https://doi.org/10.1016/j.jval.2012.02.008
Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, et al. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess 2015;19(14). https://doi.org/10.3310/hta19140
Fenwick E, Marshall DA, Levy AR, Nichol G. Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res 2006;6:52.
Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. PharmacoEconomics 2014;32:1157–70. https://doi.org/10.1007/s40273-014-0193-3
Curtis L, Burns A. Unit Costs of Health and Social Care 2015. URL: www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2015/ (accessed 27 October 2022).
GOV.UK. NHS Reference Costs 2015 to 2016. URL: www.gov.uk/government/publications/nhs-reference-costs-2015-to-2016 (accessed 27 October 2022).
NHS England. 2018/19 National Cost Collection Data Publication. URL: www.england.nhs.uk/publication/2018-19-national-cost-collection-data-publication/ (accessed 27 October 2022).
Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ 2015;350:h1258. https://doi.org/10.1136/bmj.h1258
Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness–implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care 2012;50:217–26. https://doi.org/10.1097/MLR.0b013e3182408812
Pawson R, Tilley N. Realistic Evaluation. London: SAGE Publications Ltd; 1997.
May CR, Cummings A, Girling M, Bracher M, Mair FS, May CM, et al. Using Normalization Process Theory in feasibility studies and process evaluations of complex healthcare interventions: a systematic review. Implement Sci 2018;13:80. https://doi.org/10.1186/s13012-018-0758-1
Murray E, Treweek S, Pope C, MacFarlane A, Ballini L, Dowrick C, et al. Normalisation process theory: a framework for developing, evaluating and implementing complex interventions. BMC Med 2010;8:63. https://doi.org/10.1186/1741-7015-8-63
Borrelli B, Sepinwall D, Ernst D, Bellg AJ, Czajkowski S, Breger R, et al. A new tool to assess treatment fidelity and evaluation of treatment fidelity across 10 years of health behavior research. J Consult Clin Psychol 2005;73:852–60.
Borrelli B. The assessment, monitoring, and enhancement of treatment fidelity in public health clinical trials. J Public Health Dent 2011;71:52–63.
Mannix KA, Blackburn IM, Garland A, Gracie J, Moorey S, Reid B, et al. Effectiveness of brief training in cognitive behaviour therapy techniques for palliative care practitioners. Palliat Med 2006;20:579–84.
Moorey S, Cort E, Kapari M, Monroe B, Hansford P, Mannix K, et al. A cluster randomized controlled trial of cognitive behaviour therapy for common mental disorders in patients with advanced cancer. Psychol Med 2009;39:713–23. https://doi.org/10.1017/S0033291708004169
Taylor SJC, Sohanpal R, Bremner SA, Devine A, McDaid D, Fernández J-L, et al. Self management support for moderate to severe COPD: a pilot randomised controlled trial. Br J Gen Pract 2012;63:e687–95. https://doi.org/10.3399/bjgp12X656829
Farquhar M. Improving support of informal carers of respiratory patients. Respirology 2021;1–2.
Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med 2008;38:385–96.
Lamers F, Jonkers CC, Bosma H, Chavannes NH, Knottnerus JA, van Eijk JT. Improving quality of life in depressed COPD patients: effectiveness of a minimal psychological intervention. COPD 2010;7:315–22. https://doi.org/10.3109/15412555.2010.510156
Lee H, Yoon JY, Lim Y, Jung H, Kim S, Yoo Y, et al. The effect of nurse-led problem-solving therapy on coping, self-efficacy and depressive symptoms for patients with chronic obstructive pulmonary disease: a randomised controlled trial. Age Ageing 2015;44:397–403. https://doi.org/10.1093/ageing/afu201
Perkins-Porras L, Riaz M, Okekunle A, Zhelezna S, Chakravorty I, Ussher M. Feasibility study to assess the effect of a brief mindfulness intervention for patients with chronic obstructive pulmonary disease: a randomised controlled trial. Chronic Respir Dis 2018;15:400–10.
Rosser R, Denford J, Heslop A, Kinston W, Macklin D, Minty K, et al. Breathlessness and psychiatric morbidity in chronic bronchitis and emphysema: a study of psychotherapeutic management. Psychol Med 1983;13:93–110. https://doi.org/10.1017/s0033291700050108
Schüz N, Walters JA, Cameron-Tucker H, Scott J, Wood-Baker R, Walters EH. Patient anxiety and depression moderate the effects of increased self-management knowledge on physical activity: a secondary analysis of a randomised controlled trial on health-mentoring in COPD. COPD 2015;12:502–9. https://doi.org/10.3109/15412555.2014.995289
Norton S, Cosco T, Doyle F, Done J, Sacker A. The Hospital Anxiety and Depression Scale: a meta confirmatory factor analysis. J Psychosom Res 2013;74:74–81. https://doi.org/10.1016/j.jpsychores.2012.10.010
Brennan C, Worrall-Davies A, McMillan D, Gilbody S, House A. The Hospital Anxiety and Depression Scale: a diagnostic meta-analysis of case-finding ability. J Psychosom Res 2010;69:371–8. https://doi.org/10.1016/j.jpsychores.2010.04.006
Bock K, Bendstrup E, Hilberg O, Løkke A. Screening tools for evaluation of depression in chronic obstructive pulmonary disease (COPD). A systematic review. Eur Clin Respir J 2017;4:1332931. https://doi.org/10.1080/20018525.2017.1332931
Gordon CS, Waller JW, Cook RM, Cavalera SL, Lim WT, Osadnik CR. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: a systematic review and meta-analysis. Chest 2019;156:80–91.
Doyle C, Bhar S, Fearn M, Ames D, Osborne D, You E, et al. The impact of telephone-delivered cognitive behaviour therapy and befriending on mood disorders in people with chronic obstructive pulmonary disease: a randomized controlled trial. Br J Health Psychol 2017;22:542–56. https://doi.org/10.1111/bjhp.12245
Bove DG, Overgaard D, Lomborg K, Lindhardt BØ, Midtgaard J. Efficacy of a minimal home-based psychoeducative intervention versus usual care for managing anxiety and dyspnoea in patients with severe chronic obstructive pulmonary disease: a randomised controlled trial protocol. BMJ Open 2015;5:e008031. https://doi.org/10.1136/bmjopen-2015-008031
Bove DG, Lomborg K, Jensen AK, Overgaard D, Lindhardt BØ, Midtgaard J. Efficacy of a minimal home-based psychoeducative intervention in patients with advanced COPD: a randomised controlled trial. Respir Med 2016;121:109–16.
Pumar MI, Roll M, Fung P, Rolls TA, Walsh JR, Bowman RV, et al. Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation. J Thorac Dis 2019;11:S2238–53.
Hynninen MJ, Bjerke N, Pallesen S, Bakke PS, Nordhus IH. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med 2010;104:986–94. https://doi.org/10.1016/j.rmed.2010.02.020
Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med 2003;26:1–7. https://doi.org/10.1207/S15324796ABM2601_01
Goldberg D, Gask L, O’Dowd T. The treatment of somatization: teaching techniques of reattribution. J Psychosom Res 1989;33:689–95. https://doi.org/10.1016/0022-3999(89)90084-6
Selman LE, Clement C, Douglas M, Douglas K, Taylor J, Metcalfe C, et al. Patient and public involvement in randomised clinical trials: a mixed-methods study of a clinical trials unit to identify good practice, barriers and facilitators. Trials 2021;22:735. https://doi.org/10.1186/s13063-021-05701-y
Bagley HJ, Short H, Harman NL, Hickey HR, Gamble CL, Woolfall K, et al. A patient and public involvement (PPI) toolkit for meaningful and flexible involvement in clinical trials – a work in progress. Res Involv Engagem 2016;2:15. https://doi.org/10.1186/s40900-016-0029-8
Michalovic E, Sweet SN, Jensen D. Research and healthcare priorities of individuals living with COPD. COPD 2021;18:133–46. https://doi.org/10.1080/15412555.2021.1901271
Hall A, Richmond H, Copsey B, Hansen Z, Williamson E, Jones G, et al. Physiotherapist-delivered cognitive–behavioural interventions are effective for low back pain, but can they be replicated in clinical practice? A systematic review. Disabil Rehabil 2018;40:1–9. https://doi.org/10.1080/09638288.2016.1236155
Shalom JG, Aderka IM. A meta-analysis of sudden gains in psychotherapy: outcome and moderators. Clin Psychol Rev 2020;76:101827.
Care Services Improvement Partnership. IAPT Outline Service Specification. URL: www.uea.ac.uk/documents/246046/11991919/iapt-pathfinder-outline-service-specification.pdf/9fc11891-ecc5-48e4-a974-9bbc8ab0c690 (accessed 10 November 2021).
Kazantzis N, Whittington C, Dattilio F. Meta-analysis of homework effects in cognitive and behavioral therapy: a replication and extension. Clin Psychol Sci Pract 2010;17:144–56.
Jones AW, Taylor A, Gowler H, O’Kelly N, Ghosh S, Bridle C. Systematic review of interventions to improve patient uptake and completion of pulmonary rehabilitation in COPD. ERJ Open Res 2017;3:00089–2016.
Pinnock H, Kendall M, Murray SA, Worth A, Levack P, Porter M, et al. Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ 2011;342:d142. https://doi.org/10.1136/bmj.d142
Habraken JM, Pols J, Bindels PJ, Willems DL. The silence of patients with end-stage COPD: a qualitative study. Br J Gen Pract 2008;58:844–9. https://doi.org/10.3399/bjgp08X376186
Kendall M, Buckingham S, Ferguson S, MacNee W, Sheikh A, White P, et al. Exploring the concept of need in people with very severe chronic obstructive pulmonary disease: a qualitative study. BMJ Support Palliat Care 2018;8:468–74. https://doi.org/10.1136/bmjspcare-2015-000904
Langan J, Mercer SW, Smith DJ. Multimorbidity and mental health: can psychiatry rise to the challenge? Br J Psychiatry 2013;202:391–3. https://doi.org/10.1192/bjp.bp.112.123943
National Institute of Health and Care Excellence. Multimorbidity: Clinical Assessment and Management. NICE guideline [NG56]. URL: www.nice.org.uk/guidance/ng56 (accessed 1 October 2021).
Salisbury C, Man MS, Bower P, Guthrie B, Chaplin K, Gaunt DM, et al. Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach. Lancet 2018;392:41–50.
Mercer SW, Fitzpatrick B, Guthrie B, Fenwick E, Grieve E, Lawson K, et al. The CARE Plus study – a whole-system intervention to improve quality of life of primary care patients with multimorbidity in areas of high socioeconomic deprivation: exploratory cluster randomised controlled trial and cost-utility analysis. BMC Med 2016;14:88. https://doi.org/10.1186/s12916-016-0634-2
Sturmberg JP, Getz LO, Stange KC, Upshur RE, Mercer SW. Beyond multimorbidity: what can we learn from complexity science? J Eval Clin Pract 2021;27:1187–93.
Curtis L, Burns A. Unit Costs of Health and Social Care 2018. URL: www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2018/ (accessed 27 October 2022).
Manthorpe J, Samsi K, Joly L, Crane M, Gage H, Bowling A, et al. Service provision for older homeless people with memory problems: a mixed-methods study. Health Serv Deliv Res 2019;7(9).
York Health Economic Consortium. A Return on Investment Tool for the Assessment of Falls Prevention Programmes for Older People Living in the Community. London: Public Health England; 2018.
Curtis L. Unit Costs of Health and Social Care 2014. URL: www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2014/ (accessed 27 October 2022).
Grant P. How much does a diabetes out-patient appointment actually cost? An argument for PLICS. J Health Organ Manag 2015;29:154–69.
Saf BQ. Support for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service. BMJ 2020;286:29.
Curtis L. Unit Costs of Health and Social Care 2013. URL: www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2013/ (accessed 27 October 2022).